Pluronic F127-cyclodextrin conjugate micelles for encapsulation of honokiol
Authors:
- 25 September 2018
- journal article
- research article
- Published by Springer Nature in Journal of Nanoparticle Research
- Vol. 20 (10) , 261
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2016BL15)
- Science and Technology Project of University of Jinan (XKY1732)
This publication has 26 references indexed in Scilit:
- Cyclodextrins as encapsulation agents for plant bioactive compoundsCarbohydrate Polymers, 2014
- Preparation, characterization, pharmacokinetics, and bioactivity of honokiol‐in‐hydroxypropyl‐β‐cyclodextrin‐in‐liposomeJournal of Pharmaceutical Sciences, 2011
- Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiolInternational Journal of Pharmaceutics, 2011
- Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranesJournal of Pharmacy and Pharmacology, 2011
- Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studiesInternational Journal of Nanomedicine, 2011
- Core−Shell Nanosized Assemblies Mediated by the α−β Cyclodextrin Dimer with a Tumor-Triggered Targeting PropertyACS Nano, 2010
- A novel transdermal honokiol formulation based on Pluronic F127 copolymerDrug Delivery, 2010
- In vitro drug release behavior from a novel thermosensitive composite hydrogel based on Pluronic f127 and poly(ethylene glycol)-poly(ε-caprolactone)-poly(ethylene glycol) copolymerBMC Biotechnology, 2009
- Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiersJournal of Controlled Release, 2008
- Mechanisms of action of systemic antifungal agentsJournal of the American Academy of Dermatology, 1993